by From Mayo Clinic News Network, Mayo Clinic News Network Since many people are wearing face masks because of COVID-19 pandemic requirements, skin irritations on the face might be more prevalent. “People are getting friction and irritation across their nasal bridge, behind their ears and perhaps under their chin,” says Dr. Dawn Davis, a Mayo...
Psychedelics such as LSD and magic mushrooms have proven highly effective in treating depression and post-traumatic stress disorders, but medical use of these drugs is limited by the hallucinations they cause. “What if we could redesign drugs to keep their benefits while eliminating their unwanted side effects?” asks Ron Dror, an associate professor of computer...
CHICAGO — Scientists from Northwestern Medicine and the University of Belgrade have pinpointed the electrophysiological mechanism behind upper motor neuron (UMN) disease, unlocking the door to potential treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, such as Hereditary Spastic Paraplegia and Primary Lateral Sclerosis. The study, published in Frontiers in Molecular Neuroscience on...
by Marcene Robinson, University at Buffalo Suramin, a 100-year old drug used to treat sleeping sickness, has been repurposed to fight oral mucositis and diabetic foot ulcers, according to University at Buffalo-supported research. The breakthrough, led by researchers at the University of Arizona with the support of Keith Kirkwood, DDS, Ph.D., Centennial Endowed Chair and...
by Iqbal Pittalwala, University of California – Riverside Pacific Islander young adults in the United States have an extremely high level of hazardous drinking and potential alcohol-use disorders, a study led by a health disparities researcher at the University of California, Riverside, has found. The study, published in the American Journal of Orthopsychiatry, found 56%...
Antibody-based therapies can be used to protect at-risk populations, including medical workers, from the virus. The race to develop effective antibody-based treatments for COVID-19 is advancing at a rapid pace. Now, a Tel Aviv University laboratory reports it has successfully isolated two antibodies that would neutralize the virus’s ability to infect human cells. The two...
Use of sodium-glucose cotransporter 2 (SGLT2) inhibitors to treat type 2 diabetes may help to lower the risk of serious kidney problems, according to a Scandinavian study led by researchers at Karolinska Institutet. The findings, now published in the journal The BMJ, provide support for the use of SGLT2 inhibitors in a broad range of...
by Children’s Hospital Boston Capping decades of research, a new study may offer a breakthrough in treating dyskeratosis congenita and other so-called telomere diseases, in which cells age prematurely. Using cells donated by patients with the disease, researchers at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center identified several small molecules that appear to reverse...
A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, and one of the most deadliest with a less than 10 percent, five-year survival rate. PRMT1 is involved in a number of genetic processes including gene transcription, DNA repair...
